Bone undergoes a continuous cycle of remodeling, and recent advances have elucidated many of the molecular mechanisms that regulate this process. A number of pathologic conditions in which the immune system is chronically activated have adverse effects on bone, including rheumatoid arthritis (RA) and periodontal disease. Therefore, in order to develop optimal avenues of intervention and treatment in diseases involving bone loss, it is of great importance to understand immune factors that control bone turnover. A highly complex network of inflammatory cytokines controls bone homeostasis, and strategies aimed at blocking such cytokines have shown clinical success for the treatment of RA. Recently, a new family of bone-acting cytokines was described, the founding member of which is interleukin (IL)-17. Strikingly, both Il-17 and its receptor (IL-17R) are distinct in sequence from other cytokine families (e.g., the TNF or IL-1/Toll-like receptor families). Like TNFalpha and IL-1beta, IL-17 exerts potent effects on bone and is involved in the pathogenesis of RA. In addition, IL-17 triggers the production of other cytokines, chemokines and inflammatory mediators (e.g., IL-6, IL-8, LIX/CSCL5 and PGE2), and also synergizes with various cytokines (e.g., TNFalpha, IL-1beta and IFNgamma). However, despite its central role in inflammation, very little is known about the mechanisms of action and physiological functions of this intriguing cytokine family. Knockout mice provide a powerful genetic tool with which to dissect the roles of individual genes in complex physiological processes. Recently, the IL-17R knockout mice were described. We have obtained these mice and propose to use them to address two important aspects of IL-17R-mediated signaling. First, molecular studies of the IL-17R have been hampered by the fact that it this receptor ubiquitously expressed. Therefore, we will use murine embryonic fibroblast (MEF) lines and primary calvarial osteoblasts derived from these mice to perform structure-function analyses of the IL-17R in order to define contributions of specific receptor subdomains to signal transduction. Second, no studies to date have examined bone turnover in these mice. Accordingly, we will examine the contribution of IL-17R signaling to bone metabolism in vivo using a periodontal model of bone loss. Collectively, these studies will shed light on the function of a novel family of cytokine receptors, as represented by the IL-17R.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AR050458-01A1
Application #
6865233
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Sharrock, William J
Project Start
2005-03-01
Project End
2006-12-31
Budget Start
2005-03-01
Budget End
2005-12-31
Support Year
1
Fiscal Year
2005
Total Cost
$153,412
Indirect Cost
Name
State University of New York at Buffalo
Department
Dentistry
Type
Schools of Dentistry
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Lu, Yong-Chen; Kim, Ira; Lye, Elizabeth et al. (2009) Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol 182:7212-21
Gaffen, Sarah L (2008) An overview of IL-17 function and signaling. Cytokine 43:402-7
Yu, Jeffrey J; Ruddy, Matthew J; Conti, Heather R et al. (2008) The interleukin-17 receptor plays a gender-dependent role in host protection against Porphyromonas gingivalis-induced periodontal bone loss. Infect Immun 76:4206-13
Lindemann, Matthew J; Hu, Zihua; Benczik, Marta et al. (2008) Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. J Biol Chem 283:14100-8
Maitra, Amarnath; Shen, Fang; Hanel, Walter et al. (2007) Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci U S A 104:7506-11
Yu, Jeffrey J; Ruddy, Matthew J; Wong, Grace C et al. (2007) An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109:3794-802
Khader, Shabaana A; Bell, Guy K; Pearl, John E et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369-77
Kramer, Jill M; Yi, Ling; Shen, Fang et al. (2006) Evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol 176:711-5
Gaffen, Sarah L; Kramer, Jill M; Yu, Jeffrey J et al. (2006) The IL-17 cytokine family. Vitam Horm 74:255-82
Shen, Fang; Hu, Zihua; Goswami, Jaya et al. (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281:24138-48

Showing the most recent 10 out of 11 publications